Remix.run Logo
GeekyBear 4 days ago

The fact that they were only testing a tiny group of patients (to make sure the treatment would not do more harm than good) with such astonishing remissions for two different very aggressive cancer types warms my heart.

hinkley 4 days ago | parent [-]

With an autoimmune solution I worry that you have to test on a vast number of people to determine the actual safety. And maybe even to come up with a way to determine if a candidate is in an at risk group.

And then god forbid it turns out to only work for a couple of major ethnic groups and then is starts to look like eugenics if you don’t immediately plow all the money into creating versions that work properly for everyone else.